IGI Labs (IG) Tops Q3 EPS by 5c; Will No Longer be IGI Labs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
IGI Laboratories, Inc. Announces Name Change To Teligent, Inc.
October 22, 2015 4:07 PM EDTBUENA, N.J., Oct. 22, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, announced that it will adopt Teligent, Inc. as its new name and will begin trading under a new symbol TLGT after ringing the NASDAQ Opening Bell on October 26, 2015.
''Our new name captures the energy and passion that our people feel about our future,'' said Jason Grenfell-Gardner, the Company's President and Chief Executive Officer. ''We are... More
IGI Laboratories Announces Third Quarter 2015 Results
October 22, 2015 4:05 PM EDTBUENA, N.J., Oct. 22, 2015 /PRNewswire/ --Â IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, announced its financial results for the third quarter ended September 30, 2015.
Third Quarter 2015 Highlights
Total revenues of $11.6 million in the third quarter of 2015, an increase of 74% over the same quarter in 2014 Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the third quarters of 2015 and 2014 of $8.7 million and $3.0... More